Elevai Labs Statistics
Total Valuation
Elevai Labs has a market cap or net worth of $5.83 million. The enterprise value is $6.40 million.
Important Dates
The last earnings date was Wednesday, August 14, 2024, before market open.
| Earnings Date | Aug 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Elevai Labs has 20.80 million shares outstanding. The number of shares has increased by 52.13% in one year.
| Shares Outstanding | 20.80M |
| Shares Change (YoY) | +52.13% |
| Shares Change (QoQ) | +5.59% |
| Owned by Insiders (%) | 43.83% |
| Owned by Institutions (%) | 0.73% |
| Float | 8.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.82 |
| Forward PS | n/a |
| PB Ratio | 2.19 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.59 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.05, with a Debt / Equity ratio of 0.05.
| Current Ratio | 1.05 |
| Quick Ratio | 0.07 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -72.35 |
Financial Efficiency
Return on equity (ROE) is -351.00% and return on invested capital (ROIC) is -196.46%.
| Return on Equity (ROE) | -351.00% |
| Return on Assets (ROA) | -88.55% |
| Return on Capital (ROIC) | -196.46% |
| Revenue Per Employee | $137,408 |
| Profits Per Employee | -$263,928 |
| Employee Count | 18 |
| Asset Turnover | 0.72 |
| Inventory Turnover | 1.04 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.36 |
| 200-Day Moving Average | 0.76 |
| Relative Strength Index (RSI) | 42.19 |
| Average Volume (20 Days) | 6,802,525 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Elevai Labs had revenue of $2.47 million and -$4.75 million in losses. Loss per share was -$0.32.
| Revenue | 2.47M |
| Gross Profit | 1.71M |
| Operating Income | -4.83M |
| Pretax Income | -4.62M |
| Net Income | -4.75M |
| EBITDA | -4.78M |
| EBIT | -4.83M |
| Loss Per Share | -$0.32 |
Full Income StatementBalance Sheet
The company has $100,034 in cash and $140,063 in debt, giving a net cash position of -$40,029 or -$0.00 per share.
| Cash & Cash Equivalents | 100,034 |
| Total Debt | 140,063 |
| Net Cash | -40,029 |
| Net Cash Per Share | -$0.00 |
| Equity (Book Value) | 2.64M |
| Book Value Per Share | 0.14 |
| Working Capital | 95,872 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$6.01 million and capital expenditures -$9,160, giving a free cash flow of -$6.02 million.
| Operating Cash Flow | -6.01M |
| Capital Expenditures | -9,160 |
| Free Cash Flow | -6.02M |
| FCF Per Share | -$0.29 |
Full Cash Flow StatementMargins
Gross margin is 69.25%, with operating and profit margins of -195.46% and -192.08%.
| Gross Margin | 69.25% |
| Operating Margin | -195.46% |
| Pretax Margin | -192.08% |
| Profit Margin | -192.08% |
| EBITDA Margin | -193.37% |
| EBIT Margin | -195.46% |
| FCF Margin | n/a |